UK FSA’s slow-moving novel food authorisation process feeds frustration

It’s been two years since the deadline for CBD companies to apply for the Food Standards Agency (FSA) novel foods authorisation, yet none have been authorised and few have been validated, a process that some experts say is causing the CBD market to stagnate.

“It’s not a system that’s working,” said Sarah Ellson, a partner and co-head of the regulatory group at Fieldfisher. “We have clients in other sort of food and nutrition spaces, and they’re frustrated with waits of months for products to get approved, but to have to wait years… it’s just going to kill innovation.”

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization